Article
Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 2005
Mandic Robert, Schamberger Chantal J, Müller Julia F, Geyer Matthias, Zhu Li, Carey Thomas E, Grénman Reidar, Dünne Anja A, Werner Jochen A
Abstract excerpt
PURPOSE: Head and neck squamous cell carcinomas (HNSCC) are the most frequent malignancies of the upper aerodigestive tract. Cisplatin resistance is a major problem in the treatment of a large number of HNSCC cancer patients. In this study, nine randomly selected HNSCC cell lines were investigated regarding expression, presence of mutations, nucleocytoplasmic distribution of p53, and sensitivity to cisplatin....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
